J&J Covid-19 Vaccine Authorized for Use in U.S.
The first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, JNJ -2.64% was authorized for use, a big boost
Read moreThe first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, JNJ -2.64% was authorized for use, a big boost
Read moreA committee of independent medical experts convenes Friday to review Johnson & Johnson’s JNJ 0.10% Covid-19 single-dose vaccine, the final
Read moreThe Pfizer-BioNTech COVID vaccine has shown remarkable results thus far, with a Dec. 2020 study published in the New England
Read moreAT&T Inc. agreed to sell a stake in its pay-TV unit to private-equity firm TPG and carve out the struggling
Read moreText size The State of Wisconsin Investment Board added to positions in GE, Zoom Video, and Pfizer stock, and cut
Read moreAstraZeneca’s COVID-19 vaccine has not yet been submitted for U.S. approval. Research from the University of Oxford and AstraZeneca shows
Read more“When we continue to test new vaccines, we’re testing them in a different environment where there are these strains that
Read moreThe second doses are supposed to be taken within a narrow timeframe to ensure their effectiveness. Source link
Read morePfizer Inc. PFE -3.07% said it expects its Covid-19 vaccine to generate about $15 billion in sales this year, indicating
Read moreFILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration
Read more